ArticleBMJ open2019

Fatigue, quality of life and metabolic changes in men treated with first-line enzalutamide versus abiraterone plus prednisolone for metastatic castration-resistant prostate cancer (HEAT): a randomised trial protocol.

Klara Kvorning Ternov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.